An in vitro human cell-based assay to rank the relative immunogenicity of proteins

Toxicological Sciences

Volumn 77, Issue 2, 2004, Pages 280-289

  Stickler, Marcia ^a   Rochanayon, Narapon ^a   Razo, O Jennifer ^a   Mucha, Jeanette ^a   Gebel, Wendy ^a   Faravashi, Nargol ^a   Chin, Regina ^a   Holmes, Susan ^b   Harding, Fiona A ^a  

^a Genecor International   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Cellular activation; Human antigen peptide epitopes; Immunogenicity

Indexed keywords

ALLERGEN; AMYLASE; BETA 2 MICROGLOBULIN; BETA INTERFERON; ERYTHROPOIETIN; HLA DR ANTIGEN; INDUSTRIAL ENZYME; PROTEINASE; SUBTILISIN; THROMBOPOIETIN; VEGETABLE PROTEIN;

ALLERGENICITY; AMINO ACID SEQUENCE; ANALYTIC METHOD; ARTICLE; CALCULATION; CELL ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IMMUNOASSAY; IMMUNOGENICITY; IN VITRO STUDY; MEASUREMENT; NUCLEOTIDE SEQUENCE; OCCUPATIONAL EXPOSURE; PREDICTION; PROTEIN STRUCTURE; STATISTICAL ANALYSIS; T LYMPHOCYTE;

ALLERGENS; BIOLOGICAL ASSAY; BLOOD DONORS; CD4-POSITIVE T-LYMPHOCYTES; CELLS, CULTURED; DENDRITIC CELLS; FOOD HYPERSENSITIVITY; HLA ANTIGENS; HUMANS; IMMUNODOMINANT EPITOPES; PEPTIDES; PROTEINS; RESPIRATORY HYPERSENSITIVITY; SUBTILISINS;

ANIMALIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 1342307321     PISSN: 10966080     EISSN: None     Source Type: Journal    
DOI: 10.1093/toxsci/kfh021     Document Type: Article

References (58)

1. Alving, C. R. (2002). Design and selection of vaccine adjuvants: Animal models and human trials. Vaccine 20(Suppl. 3), S56-S64.
2. Basser, R. L., O'Flaherty, E., Green, M., Edmonds, M., Nichol, J., Menchaca, D. M., Cohen, B., and Begley, C. G. (2002). Development of pancytopenia with neutralizing antibodies to thrombopoietin after multicycle chemotherapy supported by megakaryocyte growth and development factor. Blood 99, 2599-2602.
3. Bernstein, I. L., Bernstein, J. A., Miller, M., Tierzieva, S., Bernstein, D. I., Lummus, Z., Selgrade, M. K., Doerfler, D. L., and Seligy, V. L. (1999). Immune responses in farm workers after exposure to Bacillus thuringiensis pesticides. Environ. Health Perspect. 107, 575-582.
4. Black, K. E., Murray, J. A., and David, C. S. (2002). HLA-DQ determines the response to exogenous wheat proteins: A model of gluten sensitivity in transgenic knockout mice. J. Immunol. 169, 5595-5600.
5. Blaikie, L., and Basketter, D. A. (1999a). Experience with a mouse intranasal test for the predictive identification of respiratory sensitization potential of proteins. Food Chem. Toxicol. 37, 889-896.
6. Blaikie, L., and Basketter, D. A. (1999b). Strain variation in the IgG1 antibody response to proteins administered intranasally in the mouse. Food Chem. Toxicol. 37, 897-904.
7. Bono, M. R., and Strominger, J. L. (1982). Direct evidence of homology between human DC-1 antigen and murine I-A molecules. Nature 299, 836-840.
8. Boyton, R. J., and Altmann, D. M. (2002). Transgenic models of autoimmune disease. Clin. Exp. Immunol. 127, 4-11.
9. Braun, A., Kwee, L., Labow, M. A., and Alsenz, J. (1997). Protein aggregates seem to play a key role among the parameters influencing the antigenicity of interferon α (IFN-α) in normal and transgenic mice. Pharm. Res. 14, 1472-1478.
10. Brimnes, M. K., Bonifaz, L., Steinman, R. M., and Moran, T. M. (2003). Influenza virus-induced dendritic cell maturation is associated with the induction of strong T cell immunity to a coadministered, normally nonimmunogenic protein. J. Exp. Med. 198, 133-144.
11. Bussiere, J. L. (2003). Animal models as indicators of immunogenicity of therapeutic proteins in humans. Dev. Biol. 112, 135-139.
12. Casadevall, N., Nataf, J., Viron, B., Kolta, A., Kiladjian, J. J., Martin-Dupont, P., Michaud, P., Papo, T., Ugo, V., Teyssandier, I., et al. (2002). Pure red cell aplasia and antierythropoietin antibodies in patients treated with recombinant erythropoietin. N. Engl. J. Med. 346, 469-475.
13. Chamberlain, P., and Mire-Sluis, A. R. (2003). An overview of scientific and regulatory issues for the immunogenicity of biological products. Dev. Biol. 112, 3-11.
14. Chen, D., Ueda, R., Harding, F., Patil, N., Mao, Y., Kurahara, C., Platenburg, G., and Huang, M. (2003). Characterization of HLA DR3/DQ2 transgenic mice: A potential humanized animal model for autoimmune disease studies. Eur. J. Immunol. 33, 172-182.
15. Chen, Z., Dudek, N., Wijburg, O., Strugnell, R., Brown, L., Deliyannis, G., Jackson, D., Koentgen, F., Gordon, T., and McCluskey, J. (2002). A 320-kilobase artificial chromosome encoding the human HLA DR3-DQ2 MHC haplotype confers HLA restriction in transgenic mice. J. Immunol. 168, 3050-3056.
16. Das, P., Abraham, R., and David, C. (2000). HLA transgenic mice as models of human autoimmune diseases. Rev. Immunogenet. 2, 105-114.
17. Farrar, J. D., Smith, J. D., Murphy, T. L., Leung, S., Stark, G. R., and Murphy, K. M. (2000). Selective loss of type I interferon-induced STAT4 activation caused by a minisatellite insertion in mouse Stat2. Nat. Immunol. 1, 65-69.
18. Ge, Y., Powell, S., Van Roey, M., and McArthur, J. G. (2001). Factors influencing the development of an antifactor IX (FIX) immune response following administration of adeno-associated virus-FIX. Blood 97, 3733-3737.
19. Gough, L., Sewell, H. F., and Shakib, F. (2001). The proteolytic activity of the major dust mite allergen Der p1 enhances the IgE antibody response to a bystander antigen. Clin. Exp. Allergy 31, 1594-1598.
20. Guery, J. C., Sette, A., Appella, E., and Adorini, L. (1995). Constitutive presentation of dominant epitopes from endogenous naturally processed self-β2-microglobulin to class II-restricted T cells leads to self-tolerance. J. Immunol. 154, 545-554.
21. Hall, F. C., Rabinowitz, J. D., Busch, R., Visconti, K. C., Belmares, M., Patil, N. S., Cope, A. P., Patel, S., McConnell, H. M., Mellins, E. D., et al. (2002). Relationship between kinetic stability and immunogenicity of HLA-DR4/ peptide complexes. Eur. J. Immunol. 32, 662-670.
22. Harding, F. (2003). CD4+ T cell epitope identification: Applications to allergy. Clin. Exp. Allergy 33, 557-565.
23. Hileman, R. E., Silvanovich, A., Goodman, R. E., Rice, E. A., Holleschak, G., Astwood, J. D., and Hefle, S. L. (2002). Bioinformatic methods for allergenicity assessment using a comprehensive allergen database. Int. Arch. Allergy Immunol. 128, 280-291.
24. Ito, K., Bian, H. J., Molina, M., Han, J., Magram, J., Saar, E., Belunis, C., Bolin, D. R., Arceo, R., Campbell, R., et al. (1996). HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis. J. Exp. Med. 183, 2635-2644.
25. Johnsen, C., Sorensen, T., Larson, A., Secher, A., Andreasen, E., Kofoed, G., Nielsen, L., and Gyntelberg, F. (1997). Allergy risk in an enzyme-producing plant: A restrospective follow-up study. Occup. Environ. Med. 54, 671-675.
26. Kim, B. S., and Jang, Y. S. (1992). Constraints in antigen processing result in unresponsiveness to a T cell epitope of hen egg lysozyme in C57BL/6 mice. Eur. J. Immunol. 22, 775-782.
27. Kimber, I., Bernstein, I. L., Karol, M. H., Robinson, M. K., Sarlo, K., and Selgrade, M. K. (1996). Workshop overview. Identification of respiratory allergens. Fundam. Appl. Toxicol. 33, 1-10.
28. Kore, E., Zuckerman, L. A., and Mire-Sluis, A. R. (2002). Immune responses to therapeutic proteins in humans - clinical significance, assessment and prediction. Curr. Pharm. Biotechnol. 3, 349-360.
29. Kotz, S., and Johnson, N., Eds. (1988). Encyclopedia of Statistical Sciences, pp. 300, 512. John Wiley and Sons, New York.
30. Krco, C. J., Watanabe, S., Harders, J., Griffths, M. M., Luthra, H., and David, C. S. (1999). Identification of T cell determinants on human type II collagen recognized by HLA-DQ8 and HLA-DQ6 transgenic mice. J. Immunol. 163, 1661-1665.
31. Li, J., Yang, C., Xia, Y., Bertino, A., Glaspy, J., Roberts, M., and Kuter, D. J. (2001). Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood 98, 3241-3248.
32. Maeji, N. J., Bray, A. M., and Geysen, H. M. (1990). Multi-pin peptide synthesis strategy for T cell determinant analysis. J. Immunol. Methods 134, 23-33.
33. Marsh, S. G. E., Parham, P., and Barber, L. D. (2000). The HLA Facts Book. Academic Press, San Diego.
34. Mucha, J. M., Stickler, M. M., Poulose, A., Ganshaw, G., Saldajeno, M., Collier, K., Huang, M. T., and Harding, F. A. (2002). Enhanced immunogenicity of a functional enzyme by T cell epitope modification. BMC Immunol. 3, 2.
35. Nordlee, J. A., Taylor, S. L., Townsend, J. A., Thomas, L. A., and Bush, R. K. (1996). Identification of a Brazil nut allergen in transgenic soybeans. N. Engl. J. Med. 334, 688-692.
36. Oehlschlager, S., Reece, P., Brown, A., Hughson, E., Hird, H., Chisholm, J., Atkinson, H., Meredith, C., Pumphrey, R., Wilson, P., et al. (2001). Food allergy - towards predictive testing for novel foods. Food Addit. Contam. 18, 1099-1107.
37. Olsson, P. G., Hammarstrom, L., and Smith, C. I. (1991). Antigenicity of mouse monoclonal antibodies. A study on the variable region of the heavy chain. J. Theor. Biol. 151, 111-122.
38. Pepys, J., Mitchell, J., Hawkins, R., and Malo, J. L. (1985). A longitudinal study of possible allergy to enzyme detergents. Clin. Allergy 15, 101-115.
39. Pepys, J., Wells, I. D., D'Souza, M. F., and Greenberg, M. (1973). Clinical and immunological responses to enzymes of Bacillus subtilis in factory workers and consumers. Clin. Allergy 3, 143-160.
40. PRISMS Study Group. (2001). PRISMS-4: Long-term efficacy of interferon-beta-1a in relapsing MS. Neurology 56, 1628-1636.
41. Raju, R., Marietta, E., Vinasco, J., Conti-Fine, B. M., Infante, A. J., and David, C. S. (2002). Cryptic determinants and promiscuous sequences on human acetylcholine receptor: HLA-dependent dichotomy in T cell function. Hum. Immunol. 63, 237-247.
42. Robinson, M. K., Horn, P. A., Kawabata, T. T., Babcock, L. S., Fletcher, E. R., and Sarlo, K. (1998). Use of the mouse intranasal test (MINT) to determine the allergenic potency of detergent enzymes: Comparison to the guinea pig intratracheal (GPIT) test. Toxicol. Sci. 43, 39-46.
43. Sarlo, K., Adamson, G. M., and Stachlewitz, R. (2003). Evidence of allergic antibody to a Bacillus serine protease in atopic women: A retrospective study. Toxicol. Sci. 72, 229.
44. Sarlo, K., Fletcher, R., Gaines, W., and Ritz, H. L. (1997). Respiratory allergenicity of detergent enzymes in the guinea pig intratracheal test: Association with sensitization of occupationally exposed individuals. Fundam. Appl. Toxicol. 39, 44-52.
45. Sarlo, K., and Kirchner, D. B. (2002). Occupational asthma and allergy in the detergent industry: New developments. Curr. Opin. Allergy Clin. Immunol. 2, 97-101.
46. Sarlo, K., Parris, J. S., Clark, E. D., Horn, P. A,, Robinson, M. K., McCay, J. A., Peachee, V. L., Veloso, Y. L., and White, K. L. Jr. (2000). Influence of MHC background on the antibody response to detergent enzymes in the mouse intranasal test [in process citation]. Toxicol. Sci. 58, 299-305.
47. Scagnolari, C., Bellomi, F., Turriziani, O., Bagnato, F., Tomassini, V., Lavolpe, V., Ruggieri, M., Bruschi, F., Meucci, G., Dicuonzo, G., et al. (2002). Neutralizing and binding antibodies to IFN-b: Relative frequency in relapsing-remitting multiple sclerosis patients treated with different IFN-b preparations. J. Interferon Cytokine Res. 22, 207-213.
48. Schwaiger, F. W., Weyers, E., Epplen, C., Brun, J., Ruff, G., Crawford, A., and Epplen, J. T. (1993). The paradox of MHC-DRB exon/intron evolution: α-helix and β-sheet encoding regions diverge while hypervariable intronic simple repeats coevolve with β-sheet codons. J. Mol. Evol. 37, 260-272.
49. Schweigert, M. K., Mackenzie, D. P., and Sarlo, K. (2000). Occupational asthma and allergy associated with the use of enzymes in the detergent industry: A review of the epidemiology, toxicology, and methods of prevention. Clin. Exp. Allergy 30, 1511-1518.
50. Sicherer, S. H., and Sampson, H. A. (2000). Peanut and tree nut allergy. Curr. Opin. Pediatr. 12, 567-573.
51. Sonderstrup, G., Cope, A. P., Patel, S., Congia, M., Hain, N., Hall, F. C., Parry, S. L., Fugger, L. H., Michie, S., and McDevitt, H. O. (1999). HLA class II transgenic mice: Models of the human CD4+ T cell immune response. Immunol. Rev. 172, 335-343.
52. Stickler, M., Chin, R., Faravashi, N., Gebel, W., Razo, O. J., Rochanayon, N., Power, S., Valdes, A. M., Holmes, S., and Harding, F. A. (2003a). Human population-based identification of CD4(+) T cell peptide epitope determinants. J. Immunol. Methods 281, 95-108.
53. Stickler, M., Mucha, J., Estell, D., Power, S., and Harding, F. (2003b). A human dendritic cell-based method to identify CD4(+) T cell epitopes in potential protein allergens. Environ. Health Perspect. 111, 251-254.
54. Stickler, M. M., Estell, D. A., and Harding, F. A. (2000). CD4+ T cell epitope determination using unexposed human donor peripheral blood mononuclear cells. J. Immunother. 23, 654-660.
55. Vanhanen. M., Toumi, T., Nordman, H., Tupasela, O., Holmberg, P. C., Miettinen, M., Mutanen, P., and Leisola, M. (1997). Sensitization to industrial enzymes in enzyme research and production. Scand. J. Work Environ. Health 23, 385-391.
56. Vanhanen, M., Tuomi, T., Tikkainen, U., Tupasela, O., Tuomainen, A., Luukkonen, R., and Nordman, H. (2001). Sensitization to enzymes in the animal feed industry. Occup. Environ. Med. 58, 119-123.
57. Vanhanen, M., Tuomi, T., Tiikkaiinen, U., Tupasela, O., Voutilainen, R., and Nordman, H. (2000). Risk of enzyme allergy in the detergent industry. Occup. Environ. Med. 57, 121-125.
58. Zhou, L.-J., and Tedder, T.F. (1996). CD14+ blood monocytes can differentiate into functionally mature Cd38+ dendritic cells. Proc. Natl. Acad. Sci. USA 93, 2599-2592.